|
|
| Evaluation of a New Multimodal Resin for Emerging Biotherapeutics | As biotherapeutics become more complex, purification scientists need flexibility for process optimization. This 15-minute on-demand webcast, Merck & Co., Inc., presents how Bio-Rad’s Nuvia™ wPrime 2A Media, a weak anion exchange and hydrophobic interaction chromatography (AEX-HIC) mixed-mode resin, provides a broad design space and improved yields while reducing aggregates and HCPs in comparison to existing monoclonal and bispecific antibody workflows. Watch now and request a sample. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
By Bioprocess Online Live | In this segment from the Bioprocess Online Live event, panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), discuss the biggest opportunity to improve process yield and performance: reducing chromatography steps and unlocking efficiencies downstream. | |
|
|
|
|
| Packing Resins Using Verified Methods | Application Note | Cytiva | Proper packing of resins is crucial for efficient chromatography. Verified methods ensure stability, optimal flow, and reproducibility across scales using automated tools. |
|
|
| Optimize mAb Purification Using Protein A Membrane Chromatography | Poster | By M. Marinova, A.C. Lyons, M. DeVore, et al., W.L. Gore & Associates | Discover how high throughput (HTP) screening can utilize membrane chromatography at comparable consumables costs to traditional resins without compromising CQAs for prescribed therapeutics. |
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
| Built for Growth: Engineering Flexible and Scalable Bioprocessing Strategies | As biopharmaceutical manufacturing expands globally, balancing flexibility, standardization, and scalability is more critical than ever. Join this webinar to learn how a collaborative, engineering-first approach can reduce risk, simplify technology transfer, and support long-term growth. Explore real-world strategies for managing sponsor variability, establishing global manufacturing standards, and designing scalable single-use platforms that enable seamless progression from clinical to commercial production. Click here to learn more. |
|
|
|
|
| Challenges And Solutions In Lyophilization Development For ADCs | White Paper | By Gregory Sacha, Ph.D., Simtra BioPharma Solutions | Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing. |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
